Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,400 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 5 February 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at so that we can update the bibliography.


(PDF, 3MB, 197 pages)


Export 229 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Title is P  [Clear All Filters]
H. Jick, Vasilakis, C., Weinrauch, L. A., Meier, C. R., Jick, S. S., and Derby, L. E., A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation, N Engl J Med, vol. 339, pp. 719-24, 1998.
T. P. van Staa, Leufkens, H., Abenhaim, L., and Cooper, C., Postmarketing surveillance of the safety of cyclic etidronate, Pharmacotherapy, vol. 18, pp. 1121-8, 1998.
C. R. Meier, Sturkenboom, M. C., Cohen, A. S., and Jick, H., Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus, J Rheumatol, vol. 25, pp. 1515-9, 1998.
F. Haste, Charlton, J., and Jenkins, R., Potential for suicide prevention in primary care? An analysis of factors associated with suicide, Br J Gen Pract, vol. 48, pp. 1759-63, 1998.
S. S. Jick, Vasilakis, C., and Jick, H., Pregnancies and terminations after 1995 warning about third-generation oral contraceptives, Lancet, vol. 351, pp. 1404-5, 1998.
D. J. Torgerson and Dolan, P., Prescribing by general practitioners after an osteoporotic fracture, Ann Rheum Dis, vol. 57, pp. 378-9, 1998.
A. Ruigomez and Rodriguez, L. A. Garcia, Presence of diabetes related complication at the time of NIDDM diagnosis: an important prognostic factor, Eur J Epidemiol, vol. 14, pp. 439-45, 1998.
C. R. Gale, Edington, J., Coles, S. J., and Martyn, C. N., Patterns of prescribing of nutritional supplements in the United Kingdom, Clin Nutr, vol. 20, pp. 333-7, 2001.
S. Seshadri, Zornberg, G. L., Derby, L. E., Myers, M. W., Jick, H., and Drachman, D. A., Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease, Arch Neurol, vol. 58, pp. 435-40, 2001.
S. Rowlands, Devalia, H., and Lawrenson, R., Preferential prescribing of type of combined oral contraceptive pill by general practitioners to teenagers with acne, Eur J Contracept Reprod Health Care, vol. 6, pp. 9-13, 2001.
C. Ellis, Gnani, S., and Majeed, A., Prevalence and management of heart failure in general practice in England and Wales, 1994-98, Health Stat Q., pp. 17-24, 2001.
A. MFG, Prevalence of comorbid mental illness and drug use recorded in general practice: preliminary findings from the general practice research database, Drugs: education, prevention and policy, vol. 8, pp. 275-80, 2001.
R. Ryan and Majeed, A., Prevalence of ischaemic heart disease and its management with statins and aspirin in general practice in England and Wales, 1994 and 1998, Health Statistics Quartely, vol. 12, pp. 34-39, 2001.
T. P. van Staa, Abenhaim, L., Cooper, C., Zhang, B., and Leufkens, H. G., Public health impact of adverse bone effects of oral corticosteroids, Br J Clin Pharmacol, vol. 51, pp. 601-7, 2001.
J. B. Soriano, Visick, G. T., Muellerova, H., Payvandi, N., and Hansell, A. L., Patterns of comorbidities in newly diagnosed COPD and asthma in primary care, Chest, vol. 128, pp. 2099-107, 2005.
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK, BMC Cardiovasc Disord, vol. 5, p. 20, 2005.
J. M. Gelfand, Weinstein, R., Porter, S. B., Neimann, A. L., Berlin, J. A., and Margolis, D. J., Prevalence and treatment of psoriasis in the United Kingdom: a population-based study, Arch Dermatol, vol. 141, pp. 1537-41, 2005.
D. Mines, Hill, D., Yu, H., and Novelli, L., Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram, Pharmacoepidemiol Drug Saf, vol. 14, pp. 367-72, 2005.
A. G. Wade, Toumi, I., and Hemels, M. E., A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK, Curr Med Res Opin, vol. 21, pp. 631-42, 2005.
W. T. Hamilton, Gallagher, A. M., Thomas, J. M., and White, P. D., The prognosis of different fatigue diagnostic labels: a longitudinal survey, Fam Pract, vol. 22, pp. 383-8, 2005.
A. Gonzalez-Perez and Rodriguez, L. A. Garcia, Prostate cancer risk among men with diabetes mellitus (Spain), Cancer Causes Control, vol. 16, pp. 1055-8, 2005.
[Page last reviewed 5 February 2020]